推行医药企业伦理准则营造健康医药产业环境PromotingEthics.ppt

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * Session Three: Multi-Stakeholder Partnership to Strengthen Ethical Business Practices  Panel Session Members: Moderator: Mr. Russell Williams, RxD (Canada) Panelist: Hon. Kenneth Hartigan-Go, Department of Health (The Philippines) Panelist: Dr. Masami Ishii, Japan Medical Association (Japan) Panelist: Dr. Chairat Shayakul, Rational Drug Use Subcommittee (Thailand) Panelist: Mr. KP Tsang, Chair, International Alliance of Patients Organizations (Hong Kong) CLOSING SESSION WORKSHOP GROUPPHOTOGRAPH Closing Session and Workshop Group Photograph  Closing Remarks: Mr. Russell Williams, RxD (Canada) Review of Plenary Session Procedures: Mr. Andrew Blasi, CM International (United States) Workshop Group Photograph 2015 APEC Business Ethics for SMEs ForumBiopharmaceutical Sector Workshop 19 August 2015│ Manila, Philippines 2015 APEC Business Ethics for SMEs Forum Biopharmaceutical Sector Reception (Boracay Room) * * * * * * * * * * * * * * * * * * * * * * * * * * * SESSION TWOBest Practices for Low Cost Implementaton of Codes of Ethics Session Two: Best Practices for Low Cost Implementation of Codes of Ethics  Scene-Setting Remarks: SME Perspective: Mr. Butch Sales (The Philippines) Association Perspective: Sabrina Chan (Hong Kong) Exercise Facilitator: Ms. Karen Eryou, UCB (China) The Role of the Industry Association on Code of Practice Sabrina Chan Executive Director The Hong Kong Association of the Pharmaceutical Industry August 2015 Myths of implementing Code of Practice Is implementing the Code costly? Is implementing a Code time consuming? Is promoting a Code need a lot of additional human resources? Will I lose the market if my company does something different from other companies (which do not comply with the Code Of Practice); or if my company does something different from the previous practice by which I